BYHEALTH owned Life-Space’s vitamin brand for children, Pentavite, is ramping up its activity in China in a bid to keep children on the ‘supplement journey through to adolescence’.
In this round-up, we shine the spotlight on nutra trends analysis and forecast from major brands GNC, Nestle, as well as new product development from BY-HEALTH, FANCL, and more.
South Korean direct-selling company Atomy, which sells health supplements, personal care and household items, is on an expansion spree and is set to enter New Zealand in March, and later in Turkey and the UK.
The Indian firm behind an ayurvedic cannabis product for alleviating menstrual cramps has unveiled plans on expanding its product range to cover chronic pain relief.
FANCL has launched a new immune supplement that uses technology to protect tablets from premature disintegration during the production and storage process.
Malaysia headquartered Ritamix Global has launched a tea modelled on a TCM formula used in China for COVID-19 treatment – but the new product is registered as food and beverage and makes no health claims.
Singapore dietary supplement brands are seeing a number of key growth opportunities in China, including the demand for eye health products, while women and youths have been identified as the key consumer groups.
Vietnam, India and the regional halal market are on the radar for supplement companies when it comes to their expansion plans, according to a raft of top companies.
Malaysia-based and Australia-listed food tech firm Holista Colltech has set its sights on marketing its low-GI bread premix in several APAC markets after a successful partnership in the United States with bakery manufacturer Costanzo’s.
E-commerce giant JD has seen a boom in organic product sales in China after working with brand partners to establish the country’s first-ever organic alliance, with the firm saying demand has been boosted by consumers seeking 'safer and healthier'...
The business environment has been hard hit by COVID-19 and small players are usually the most affected, but two APAC nutra start-ups are flourishing amid the crisis.
Nestlé is launching a milk product for adults, consisting of a unique combination of ingredients supporting what the company said are the three pillars of mobility: bone health, muscle strength and joint functionality.
ASX-listed MGC Pharma is in talks with South East Asia (SEA) countries to make its clinically backed oral supplement trademarked ArtemiC commercially available for COVID-19 patients.
